Skip to main content
Surgical Case Reports
Fig. 1 | Surgical Case Reports

Fig. 1

From: Hypothyroidism and hypopituitarism as immune-related adverse events due to lenvatinib plus pembrolizumab therapy in the immediate postoperative period after laparoscopic hepatectomy for liver metastases from gastric cancer: a case report

Fig. 1

Computed tomography images before and after lenvatinib plus pembrolizumab treatment. (orange arrow) a Metastatic tumor in segment 6 before treatment. b Metastatic tumor in segment 6 after treatment. c Metastatic tumor in segment 7 before treatment. d Metastatic tumor in segment 7 after treatment

Back to article page